Skip to main content

Avalo Therapeutics, Inc.

AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534120

In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Avalo Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of AVTX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders97126+29
Shares31.5M70.8M+39.3M (+124.9%)
Value$469.6M$1.31B+$838.0M (+178.5%)

New holders (56)

Institutions that held Avalo Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to AVTX in Q2 2026
InstitutionSharesValue% of portfolio
Deep Track Capital, LP3,610,000$66.7M0.98%
Braidwell LP1,629,182$30.1M1.11%
Price T Rowe Associates Inc1,311,715$24.2M0.00%
Alliancebernstein L.P.1,260,689$23.3M0.01%
Trails Edge Capital Partners, LP891,881$16.5M2.62%
Vestal Point Capital, LP775,000$14.3M0.33%
Parkman Healthcare Partners LLC766,290$14.2M1.45%
Baker Bros. Advisors LP550,000$10.2M0.05%
Silverarc Capital Management, LLC500,402$9.25M1.03%
Davern Capital Partners, LP468,666$8.66M1.48%
Franklin Resources Inc404,191$7.47M0.00%
DV Equities, LLC332,213$6.14M0.89%
Schonfeld Strategic Advisors LLC310,008$5.73M0.03%
Vanguard Portfolio Management LLC284,702$5.26M0.00%
Vivo Capital, LLC275,000$5.08M0.46%
Eagle Health Investments LP235,093$4.34M0.72%
Sphera Funds Management Ltd.232,294$4.29M0.61%
Walleye Capital LLC185,613$3.43M0.02%
Ally Bridge Group (NY) LLC150,000$2.77M3.57%
CenterBook Partners LP132,869$2.46M0.12%
Sectoral Asset Management Inc119,923$2.22M1.55%
Wellington Management Group LLP105,261$1.95M0.00%
Bank of New York Mellon Corp102,653$1.90M0.00%
Nuveen, LLC100,633$1.86M0.00%
Ikarian Capital, LLC90,183$1.67M0.27%
Citigroup Inc69,014$1.28M0.00%
Rafferty Asset Management, LLC56,411$1.04M0.00%
Manufacturers Life Insurance Company, The53,799$994.2K0.00%
Rhumbline Advisers53,290$984.8K0.00%
Verition Fund Management LLC38,240$706.7K0.00%
Wells Fargo & Company36,576$675.9K0.00%
Verdad Advisers, LP32,827$606.6K0.58%
Profund Advisors LLC28,309$523.1K0.01%
Susquehanna International Group, LLP27,227$503.2K0.00%
Mirae Asset Global ETFs Holdings Ltd.25,712$480.5K0.00%
MetLife Investment Management24,499$452.7K0.00%
Invesco Ltd.22,226$410.7K0.00%
Virtus Investment Advisers, Inc.22,168$409.7K0.10%
New York State Common Retirement Fund14,700$271.7K0.00%
Jain Global LLC12,686$234.4K0.00%
Woodline Partners LP12,544$231.8K0.00%
Police & Firemen's Retirement System of New Jersey12,324$227.7K0.00%
Fox Run Management, L.L.C.10,639$196.6K0.03%
Lynx1 Capital Management LP10,100$186.6K0.02%
Eversept Partners, LP10,000$184.8K0.01%
Byrne Asset Management LLC4,798$88.7K0.05%
Legal & General Group Plc4,055$74.9K0.00%
Ameritas Investment Partners, Inc.3,792$70.1K0.00%
Russell Investments Group, Ltd.3,341$61.7K0.00%
Tower Research Capital LLC (TRC)1,542$28.5K0.00%
Pacer Advisors, Inc.942$17.0K0.00%
California State Teachers Retirement System575$10.6K0.00%
Sterling Capital Management LLC490$9.05K0.00%
Rothschild Investment LLC35$6470.00%
Fifth Third Bancorp29$5360.00%
Assetmark, Inc22$4070.00%

Sold out (27)

Institutions that held Avalo Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.